Louise Frederika Kooij, Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS), sold 105,000 shares at $29.96 ($3.2M) on 2026-07-20, disclosed to the SEC on 2026-07-22.
Scheduled sale ($3.2M) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.96 | 70,200 | $2.1M | 66.0% |
| 2 | $31.05 | 31,885 | $990K | 31.1% |
| 3 | $31.71 | 2,915 | $92K | 2.9% |
| Total | $30.34 avg | 105,000 | $3.2M | 100% |
| Filing → |
| NAMS | SELL | 2026-01-29 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-27 | $2.4M | — | Filing → |
| NAMS | SELL | 2026-01-07 | $88K | — | Filing → |